Cargando…

Engineering an enhanced thrombin-based GLP-1 analog with long-lasting glucose-lowering and efficient weight reduction

Peptides are considered as potent therapeutic drugs primarily due to the exquisite potency and selectivity to targets. However, the development and clinical application of peptide drugs were severely limited by the poor in vivo lifespans. Here, we designed an improved small albumin-binding polypepti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Hongchao, Xie, Yini, Lu, Wenying, Chen, Yin, Lu, Zhao, Zhen, Jun, Wang, Weiwei, Shang, Anquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2019
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072222/ https://www.ncbi.nlm.nih.gov/pubmed/35529389 http://dx.doi.org/10.1039/c9ra06771j

Ejemplares similares

Design and biological evaluation of novel BF-30 analogs for the treatment of malignant melanoma
por: Qi, Jia, et al.
Publicado: (2020)

Design and evaluation of novel thrombin-based GLP-1 analogs with peptidic albumin binding domain for the controlled release of GLP-1
por: Niu, Xianli, et al.
Publicado: (2020)

Inhibin β-A (INHBA) induces epithelial–mesenchymal transition and accelerates the motility of breast cancer cells by activating the TGF-β signaling pathway
por: Yu, Yingying, et al.
Publicado: (2021)

Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment
por: Gejl, Michael, et al.
Publicado: (2017)

Combined Amylin/GLP-1 pharmacotherapy to promote and sustain long-lasting weight loss
por: Liberini, Claudia G., et al.
Publicado: (2019)

GLP-1 Analog Liraglutide Improves Vascular Function in Polymicrobial Sepsis by Reduction of Oxidative Stress and Inflammation
por: Helmstädter, Johanna, et al.
Publicado: (2021)

The Effects of a GLP-1 Analog on Glucose Homeostasis in Type 2 Diabetes Mellitus Quantified by an Integrated Glucose Insulin Model
por: Røge, RM, et al.
Publicado: (2015)

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression
por: Shang, Anquan, et al.
Publicado: (2020)

Oral GLP1 Analog: Where Does the Tide Go?
por: Gardner, Hannah, et al.
Publicado: (2020)

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
por: Astrup, A, et al.
Publicado: (2012)

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
por: Rowlands, Jordan, et al.
Publicado: (2018)

Histone Methyltransferase SETDB1 Promotes Immune Evasion in Colorectal Cancer via FOSB-Mediated Downregulation of MicroRNA-22 through BATF3/PD-L1 Pathway
por: Tian, Jiale, et al.
Publicado: (2022)

Robust Reductions of Body Weight and Food Intake by an Oxytocin Analog in Rats
por: Elfers, Clinton T., et al.
Publicado: (2021)

Habitual physical activity is associated with lower fasting and greater glucose-induced GLP-1 response in men
por: Janus, Charlotte, et al.
Publicado: (2019)

GLP-1 Analog Alleviated Cognitive Dysfunction in Aged Rats Anaesthetized with Sevoflurane
por: Zhang, Qin, et al.
Publicado: (2022)

Protective effect of GLP-1 analog liraglutide on podocytes in mice with diabetic nephropathy
por: Shi, Shaomin, et al.
Publicado: (2023)

Novel GLP-1 Analog Supaglutide Stimulates Insulin Secretion in Mouse and Human Islet Beta-Cells and Improves Glucose Homeostasis in Diabetic Mice
por: Ren, Liwei, et al.
Publicado: (2019)

SAT028 Beneficial Effect On Intestinal Growth Of A Long-Acting GLP-2 Analog, HM15912, After Treatment Switching From Conventional GLP-2 Drug Or Other Long-Acting GLP-2 Analogs Under Clinical Development In Animal Model
por: Park, Cho Rong, et al.
Publicado: (2023)

Exosomal KRAS mutation promotes the formation of tumor-associated neutrophil extracellular traps and causes deterioration of colorectal cancer by inducing IL-8 expression
por: Shang, Anquan, et al.
Publicado: (2020)

Glucose lowering and vascular protective effects of cycloset added to GLP‐1 receptor agonists in patients with type 2 diabetes
por: Alatrach, Mariam, et al.
Publicado: (2018)

Mo1622: EFFICACY OF GLP-1 ANALOGS AND AGONISTS ON PROPORTION OF WEIGHT LOSS IN OVERWEIGHT OR OBESE DIABETICS AND NONDIABETICS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Vosoughi, Kia, et al.
Publicado: (2022)

The potential therapeutic value and application prospect of engineered exosomes in human diseases
por: Liu, Gege, et al.
Publicado: (2022)

Engineered mRNA-expressed bispecific antibody prevent intestinal cancer via lipid nanoparticle delivery
por: Wu, Lipei, et al.
Publicado: (2021)

Anti-diabetic effects of GLP1 analogs are mediated by thermogenic interleukin-6 signaling in adipocytes
por: Gutierrez, Absalon D., et al.
Publicado: (2022)

Thrombin aggravates hypoxia/reoxygenation injury of astrocytes by activating the autophagy pathway mediated by SPRED2
por: Wang, Xiaoning, et al.
Publicado: (2021)

Thrombin Aggravates Hypoxia/Reoxygenation Injury of Cardiomyocytes by Activating an Autophagy Pathway-Mediated by SIRT1
por: Wang, Xiaoning, et al.
Publicado: (2021)

In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
por: Gejl, Michael, et al.
Publicado: (2016)

FRI639 Effect Of Early Initiation Of GLP-1 RAs On Weight Reduction Among People With Type 2 Diabetes
por: Chinthammit, Chanadda, et al.
Publicado: (2023)

Long-Lasting Effects of GSPE on Ileal GLP-1R Gene Expression Are Associated with a Hypomethylation of the GLP-1R Promoter in Female Wistar Rats
por: Ginés, Iris, et al.
Publicado: (2019)

Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9–36 Amide at the GLP-1 Receptor
por: Li, Naichang, et al.
Publicado: (2012)

Engineering collagenous analogs of connective tissue extracellular matrix
por: Brudnicki, Philip A. P., et al.
Publicado: (2022)

Glucose in the hypothalamic paraventricular nucleus regulates GLP-1 release
por: Ma, Yue, et al.
Publicado: (2020)

Carbohydrate-last meal pattern lowers postprandial glucose and insulin excursions in type 2 diabetes
por: Shukla, Alpana P, et al.
Publicado: (2017)

Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils
por: Shang, Anquan, et al.
Publicado: (2019)

Correction to: Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils
por: Shang, Anquan, et al.
Publicado: (2020)

Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
por: Mroz, Piotr A., et al.
Publicado: (2018)

The Human GLP-1 Analog Liraglutide and the Pancreas: Evidence for the Absence of Structural Pancreatic Changes in Three Species
por: Nyborg, Niels C.B., et al.
Publicado: (2012)

Effect of the GLP-1 Analog Exendin-4 and Oxaliplatin on Intrahepatic Cholangiocarcinoma Cell Line and Mouse Model
por: Chen, Ben-Dong, et al.
Publicado: (2013)

Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications
por: Manandhar, Bikash, et al.
Publicado: (2014)

Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment
por: Agersnap, Mikkel Askjær, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_la1drf8ivdlhq9390pgqj8u9af